Soleno Therapeutics, Inc.SLNONASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-3.84%
↑ 65% above average
Average (9y)
-10.98%
Historical baseline
Range
High:-3.47%
Low:-25.01%
CAGR
-12.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -3.84% | -2.2% |
| 2023 | -3.76% | +85.0% |
| 2022 | -25.01% | -47.2% |
| 2021 | -17.00% | -307.0% |
| 2020 | -4.18% | -20.5% |
| 2019 | -3.47% | +46.8% |
| 2018 | -6.52% | +47.1% |
| 2017 | -12.32% | +42.9% |
| 2016 | -21.55% | -77.2% |
| 2015 | -12.16% | - |